Seung-Beom Hong
2PUBLICATIONS
4CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (2)
Sort by Publication Date:
|Dec 23, 2023
The Defined TLR3 Agonist, Nexavant, Exhibits Anti-Cancer Efficacy and Potentiates Anti-PD-1 Antibody Therapy by Enhancing Immune Cell Infiltration.Seung-Hwan Lee, Young-Ho Choi, Soon Myung Kang
|Mar 30, 2021
A Novel Therapeutic Anti-ErbB3, ISU104 Exhibits Potent Antitumorigenic Activity by Inhibiting Ligand Binding and ErbB3 Heterodimerization.Mirim Hong, Youngki Yoo, Miyoung Kim
Pageof 1

